Samuel Agresta

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Agresta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Medical Officer Stock Options (Right to buy) 60,000 $183,600 $3.06 11 Sep 2023 Direct
INFINITY PHARMACEUTICALS, INC. Director Stock Option(right to buy) 45,000 16 Jun 2022 Direct
OnKure Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 45,000 27 Jan 2025 Direct
Foghorn Therapeutics Inc. Chief Medical Officer Common Stock 0 $8.25 16 Aug 2023 Direct

Insider Reports Filed by Samuel Agresta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR OnKure Therapeutics, Inc. 27 Jan 2025 1 $0 4 Chief Medical Officer 29 Jan 2025, 20:33
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 2 $0 4 Chief Medical Officer 08 Oct 2024, 19:20
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 Chief Medical Officer 08 Oct 2024, 19:06
FHTX Foghorn Therapeutics Inc. 11 Sep 2023 0 $0 4 Chief Medical Officer 13 Sep 2023, 17:02
FHTX Foghorn Therapeutics Inc. 16 Aug 2023 3 -$1,410,175 4 Chief Medical Officer 18 Aug 2023, 17:03
FHTX Foghorn Therapeutics Inc. 26 Jan 2023 1 $0 4 Chief Medical Officer 30 Jan 2023, 16:04
INFI INFINITY PHARMACEUTICALS, INC. 16 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:42
FHTX Foghorn Therapeutics Inc. 26 Jan 2022 1 $0 4 Chief Medical Officer 28 Jan 2022, 15:27
INFI INFINITY PHARMACEUTICALS, INC. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:16